Lisa Swanson, MD: Things to Consider When Starting Patients on JAK Inhibitors episode artwork

EPISODE · Jun 23, 2022 · 4 MIN

Lisa Swanson, MD: Things to Consider When Starting Patients on JAK Inhibitors

from The Journal of Clinical and Aesthetic Dermatology · host JCAD

Send us Fan MailLisa Swanson, MD, a board-certified dermatologist and pediatric dermatologist with Ada West Dermatology in Boise, Idaho, reviews the role that Janus kinases (JAKs) play in the inflammatory process and the benefits of inhibiting this enzyme when treating patients with atopic dermatitis. She also elaborates upon her experiences using the newly approved JAK inhibitors in her own patients. Dr. Swanson then outlines things to consider before starting patients on JAK inhibitors. 

Episode metadata supplied by the publisher feed · Published Jun 23, 2022

Embed this episode

Ready to play

Lisa Swanson, MD: Things to Consider When Starting Patients on JAK Inhibitors

0:00 4:34

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Journal of Clinical and Aesthetic Dermatology?

This episode is 4 minutes long.

When was this The Journal of Clinical and Aesthetic Dermatology episode published?

This episode was published on June 23, 2022.

Can I download this The Journal of Clinical and Aesthetic Dermatology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!